검색어: nov rt t (라트비아어 - 영어)

eiropas publisk nov rt juma zi ojums (epar)
european public assessment report (epar)

Šis dokuments ir eiropas publisk nov rt juma (epar) kopsavilkums.
this document is a summary of the european public assessment report (epar).

nav veikti p t jumi, lai nov rt tu ietekmi uz sp ju vad t transportl dzek us un apkalpot meh nismus.
no studies on the effects on the ability to drive and use machines have been performed.

Šis dokuments ir eiropas publisk nov rt juma zi ojuma (epar) kopsavilkums.
this document is a summary of the european public assessment report (epar).

lai nov rt tu iepriekš j s devas atbilst bu, ir j izmanto pirms - šanas glikozes l me a asin s r d t ji.
pre-meal blood glucose levels should be used to evaluate the adequacy of the preceding dose.

sadal juma l menis tiek nov rt ts k 193 l p c intravenozas 5 mg oksibutin na hidrohlor da ievad šanas.
the volume of distribution was estimated to be 193 l after intravenous administration of 5 mg oxybutynin hydrochloride.

profilakses un terapijas p t jumos nov rt ja citu vienlaic gi lietotu z u ietekmi uz raloksif na koncentr ciju plazm.
the influence of concomitant medication on raloxifene plasma concentrations was evaluated in the prevention and treatment trials.

taj ir paskaidrots, k cilv kiem paredz to z u komiteja (chmp) nov rt ja veiktos p t jumus, pirms sniegt ieteikumus par z u lietošanu.
it explains how the committee for medicinal products for human use (chmp) assessed the studies performed, to reach their recommendations on how to use the medicine.

taj ir paskaidrots, k cilv kiem paredz to z u komiteja (chmp) nov rt ja veiktos p t jumus, pirms sniegt ieteikumus par šo z u lietošanu.
it explains how the committee for medicinal products for human use (chmp) assessed the studies performed, to reach their recommendations on how to use the medicine.

2.4.2. att┨ls « vid┨jais nov┨rt┨ùanu un izmekl┨ùanu ilgums
chart 2.4.2. ̋ average length of assessments and investigations

novomix 30 lietošana kombin cij ar pioglitazonu var tikt apsv rta tikai p c tam, kad pacientam veikta ar š idrumu saist to blakuspar d bu paz mju vai simptomu rašan s riska kl niska nov rt šana.
the combination of novomix 30 with pioglitazone should only be considered following clinical evaluation of the patient’ s risk of developing signs or symptoms of fluid-related adverse events.

nosl �dzoties pirmajam festiv �lam, tiks nov �rt �ti daž �di t � tiv �lu “no debes �m”,
(in an f e s t i v a l , t h e artist’s residence in be evaluated in order to help organise future festivals. this

tika veikts 24 ned u placebo kontrol ts p t jums, kur nov rt ja sitaglipt na (100 mg vienu reizi dien) kombin cijas ar glimepir du vai kombin cijas ar glimepir du un metform nu droš bu un efektivit ti.
a 24-week placebo-controlled study was designed to evaluate the efficacy and safety of sitagliptin (100 mg once daily) added to glimepiride alone or glimepiride in combination with metformin.

+ nodrošin �ja, ka ne- viens ciematnieks netiek atst �ts nov �rt � un visi jaunie cil-v �ki, neraugoties uz vecumu, ieg �st sev piem �rotas rota �u vietas.
this was justified not only by the level of innovation and low level of cost, but also by the level of partnership working between the school and the parish council, without which the project would not have been possible.